Outcome of Board Meeting

Pat NegativeExceptional ItemEbitda Margin CompressionResults View source PDF

TTKHLTCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+4.6%1-day move

₹886.20

prior close

₹920.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+2.7-0.4-0.3+1.6+4.6+2.2+4.7+2.5+0.4-1.0+4.9+2.1——

Up moveDown movePending

AI summary

TTK Healthcare reported FY2026 revenue of Rs.85,728 lakhs, up 7% from Rs.80,149 lakhs in FY2025. However, Profit After Tax declined 19.6% to Rs.6,568 lakhs from Rs.8,166 lakhs, mainly due to exceptional charges of Rs.758 lakhs from new Labour Code provisions (gratuity and compensated absences) offset partly by Rs.350 lakhs GST refund. EBITDA margin compressed as material costs rose to Rs.40,349 lakhs from Rs.36,892 lakhs. The Board recommended a dividend of Rs.10 per share (100%). Statutory auditors issued an unmodified opinion confirming clean financials.

Likely market impact

The profit decline despite revenue growth is concerning for shareholders. The exceptional labour code charge is non-recurring but reflects regulatory headwinds. Positive signals include dividend declaration and unchanged auditor opinion.